The total number of records retrieved from this search are 4. Click on ID to see further detail.

ID	Virus name	Virus strain	Virus genome type	Virus family	Virus genome modification	Virus alone	Virus in combination with drug/radiation	Immune gene insertion in viral genome	Source of cell line	Origin of cell line	Cell line	Concentration of cell line	In-vitro toxicity	Assay	In-vitro virus concentration	In-vitro result	Model organism	In-vivo virus concentration	In-vivo toxicity	In-vivo result	Mode of delivery	Pathway induced	Immunogenic effect	Clinical trial	PMID
IDOV_2858	Virus nameAdenovirus	Virus strainSG7605-11R-p53	Virus genome typeDNA	Virus familyAdenoviridae	Virus genome modificationAddition of p53 gene and 11R CPP	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineEastern hepatobility hospital	Origin of cell lineGallbladder cancer cell line	Cell lineEH-GB1	Concentration of cell line1.0E+5 cells per well	In-vitro toxicityNA	AssayMTT assay	In-vitro virus concentration0.1 MOI	In-vitro result100% cell survival	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedIncrease in apoptosis rate to 67% in cancer cell compared to normal	Immunogenic effectNA	Clinical trialNA	PMID23586034
IDOV_2859	Virus nameAdenovirus	Virus strainSG7605-11R-p53	Virus genome typeDNA	Virus familyAdenoviridae	Virus genome modificationAddition of p53 gene and 11R CPP	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineEastern hepatobility hospital	Origin of cell lineGallbladder cancer cell line	Cell lineEH-GB1	Concentration of cell line1.0E+5 cells per well	In-vitro toxicityNA	AssayMTT assay	In-vitro virus concentration1 MOI	In-vitro result50% cell survival	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedIncrease in apoptosis rate to 67% in cancer cell compared to normal	Immunogenic effectNA	Clinical trialNA	PMID23586034
IDOV_2860	Virus nameAdenovirus	Virus strainSG7605-11R-p53	Virus genome typeDNA	Virus familyAdenoviridae	Virus genome modificationAddition of p53 gene and 11R CPP	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineEastern hepatobility hospital	Origin of cell lineGallbladder cancer cell line	Cell lineEH-GB1	Concentration of cell line1.0E+5 cells per well	In-vitro toxicityNA	AssayMTT assay	In-vitro virus concentration10 MOI	In-vitro result20% cell survival	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedIncrease in apoptosis rate to 67% in cancer cell compared to normal	Immunogenic effectNA	Clinical trialNA	PMID23586034
IDOV_2861	Virus nameAdenovirus	Virus strainSG7605-11R-p53	Virus genome typeDNA	Virus familyAdenoviridae	Virus genome modificationAddition of p53 gene and 11R CPP	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineEastern hepatobility hospital	Origin of cell lineGallbladder cancer cell line	Cell lineEH-GB1	Concentration of cell line1.0E+5 cells per well	In-vitro toxicityNA	AssayMTT assay	In-vitro virus concentration100 MOI	In-vitro result10% cell survival	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedIncrease in apoptosis rate to 67% in cancer cell compared to normal	Immunogenic effectNA	Clinical trialNA	PMID23586034